Association of Phenylacetylglutamine and Cognitive Impairment in CKD
Introduction: Chronic kidney disease (CKD) leads to the accumulation of uremic toxins (UTs). Studies have suggested that UTs are associated with cognitive impairment (CI) in patients with CKD. Recently, studies reported that phenylacetylglutamine (PAG) contributes to the association between CKD and...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2025-08-01
|
| סדרה: | Kidney International Reports |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2468024925003407 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
